Dahl Baunwall, S. M., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T. M. M., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2022). Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 7(12), 1083-1091. https://doi.org/10.1016/S2468-1253(22)00276-X

Hammeken, L. H., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L. & Ehlers, L. H. (2022). Health-related quality of life in patients with recurrent Clostridioides difficile infections. Therapeutic Advances in Gastroenterology, 15. https://doi.org/10.1177/17562848221078441

Ianiro, G., Mullish, B. H., Iqbal, T. H., Terveer, E. M., Baunwall, S. M. D., Link, A., Sokol, H., Kupcinskas, J., Masucci, L., Sanguinetti, M., Vehreschild, M. J. G. T., Hvas, C. L., Keller, J. J., Gasbarrini, A., Kujiper, E. J. & Cammarota, G. (2022). Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. The Lancet Gastroenterology and Hepatology, 7(11), 979-980. https://doi.org/10.1016/S2468-1253(22)00305-3

Keller, J. J., Ooijevaar, R. E., Hvas, C. L., Terveer, E. M., Lieberknecht, S. C., Högenauer, C., Arkkila, P., Sokol, H., Gridnyev, O., Mégraud, F., Kump, P. K., Nakov, R., Goldenberg, S. D., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O. ... Vehreschild, M. J. (2021). A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterology Journal, 9(2), 229-247. https://doi.org/10.1177/2050640620967898

Baunwall, S. M. D., Dahlerup, J. F., Engberg, J. H., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., Vinter-Jensen, L. & Hvas, C. L. (2021). Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scandinavian Journal of Gastroenterology, 56(9), 1056-1077. https://doi.org/10.1080/00365521.2021.1922749

Hammeken, L. H., Baunwall, S. M. D., Hvas, C. L. & Ehlers, L. H. (2021). Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review. Health Economics Review, 11(1), Article 3. https://doi.org/10.1186/s13561-021-00301-7

Ianiro, G., Mullish, B. H., Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., Kelly, C. R., Allegretti, J. R., Fischer, M., Iqbal, T. H., Satokari, R., Kao, D., Prehn, J. V., Ng, S. C., Bibbò, S., Baunwall, S. M. D., Quraishi, M. N., Sokol, H., Zhang, F. ... Cammarota, G. (2021). SARS-CoV-2 vaccines and donor recruitment for FMT. The Lancet. Gastroenterology & hepatology, 6(4), 264-266. https://doi.org/10.1016/S2468-1253(21)00032-7

Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L. & Hansen, L. H. (2021). Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy. Therapeutic Advances in Gastroenterology, 14. https://doi.org/10.1177/17562848211041004

Baunwall, S. M. D., Terveer, E. M., Dahlerup, J. F., Erikstrup, C., Arkkila, P., Vehreschild, M. JGT., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., Satokari, R., De Looze, D., Vermeire, S., Nakov, R., Brezina, J., Helms, M., Kjeldsen, J., Rode, A. A., Kousgaard, S. J. ... Hvas, C. L. (2021). The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. The Lancet Regional Health - Europe, 9, Article 100181. https://doi.org/10.1016/j.lanepe.2021.100181

Keller, J. J., Vehreschild, M. J., Hvas, C. L., Jørgensen, S. M., Kupcinskas, J., Link, A., Mulder, C. J., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2020). Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed. United European Gastroenterology Journal, 8(3), 353-354. https://doi.org/10.1177/2050640620910847

Hvas, C. L., Baunwall, S. M. D. & Erikstrup, C. (2020). Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine, 24, Article 100436. https://doi.org/10.1016/j.eclinm.2020.100436

Jørgensen, S. M. D., Rubak, T. M. M., Damsgaard, E. M., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation as a home therapy to frail older people. Age and Ageing, 49(6), 1093-1096. https://doi.org/10.1093/ageing/afaa073

Bahl, M. I., Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A., Wang, M., Licht, T. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae. Scandinavian Journal of Gastroenterology, 55(5), 626-630. https://doi.org/10.1080/00365521.2020.1753806

Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine, 29-30, Article 100642. https://doi.org/10.1016/j.eclinm.2020.100642

Jørgensen, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L., Hammeken, L. H., Licht, T. R., Bahl, M. I. & Erikstrup, C. (2019). Banking feces: a new frontier for public blood banks? Transfusion, 59(9), 2776-2782. https://doi.org/10.1111/trf.15422

Dehlholm-Lambertsen, E., Hall, B. K., Jørgensen, S. M. D., Jørgensen, C. W., Jensen, M. E., Larsen, S., Jensen, J. S., Ehlers, L., Dahlerup, J. F. & Hvas, C. L. (2019). Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 12, Article 1756284819843002. https://doi.org/10.1177/1756284819843002

Grosen, A. K., Povlsen, J., Lemming, L. E., Dahl Jørgensen, S. M., Dahlerup, J. F. & Hvas, C. L. (2019). Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae  from a Renal Transplant Recipient with Recurrent Urinary Tract Infections. Case Reports in Nephrology and Dialysis, 9(2), 102-107. https://doi.org/10.1159/000502336

Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F. (2019). Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology, 156(5), 1324-1332.e3. https://doi.org/10.1053/j.gastro.2018.12.019

Keller, J. J., Vehreschild, M. JGT., Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2019). Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. United European Gastroenterology Journal, 7(10), 1408-1410. https://doi.org/10.1177/2050640619887579

Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F. & Agnholt, J. (2018). Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology, 40(6), 446-460. https://doi.org/10.1080/08923973.2018.1469144